Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 361
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
The constitutive activation of STAT3 gene and its mutations are at the crossroad between LGL leukemia and autoimmune disorders 2024 Calabretto, GiuliaTeramo, AntonellaGasparini, Vanessa RebeccaRampazzo, ElisaZambello, Renato + BLOOD CANCER JOURNAL - -
Pro-inflammatory cells sustain leukemic clonal expansion in T-cell large granular lymphocyte leukemia 2024 Gasparini V. R.Teramo A.Calabretto G.Rampazzo E.Carraro S.Trimarco V.Trentin L.Facco M.Zambello R. + HAEMATOLOGICA - -
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group 2024 Sartori, RobertoPavan, LauraZambello, Renato + ANNALS OF HEMATOLOGY - -
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials 2024 Zambello, RenatoTarantini, GiuseppeRizzi, Rita + HAEMATOLOGICA - -
Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma 2024 Zambello, Renato + BLOOD - -
Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital 2023 Scapinello, GretaGrassi, AngelaVisentin, AndreaPavan, LauraManni, SabrinaVianello, FabrizioBriani, ChiaraZambello, RenatoTrentin, LivioPiazza, Francesco + HEMASPHERE - -
Imaging minimal residual disease evaluation in multiple myeloma using [18F]FDG PET/MRI 2023 Crimì, FilippoPavan, LauraCabrelle, GiulioCecchin, DiegoZambello, Renato + LEUKEMIA & LYMPHOMA - -
Not all LGL leukemias are created equal 2023 Calabretto, GiuliaGasparini, Vanessa RebeccaTeramo, AntonellaZambello, Renato + BLOOD REVIEWS - -
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies 2023 D’Amore, FabioPavan, LauraPiazza, FrancescoPravato, StefanoScapinello, GretaVianello, FabrizioZambello, RenatoPadoan, AndreaTrentin, LivioVisentin, Andrea + FRONTIERS IN ONCOLOGY - -
Real-world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and Israel 2023 Zambello, Renato + EJHAEM - -
Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patients 2023 Teramo A.Calabretto G.Gasparini V. R.Zambello R. + BLOOD - -
Lenalidomide-based triplet regimens in first relapsed multiple myeloma patients: real-world evidence from a propensity score matched analysis 2023 Zambello, Renato + HAEMATOLOGICA - -
Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial 2023 Zambello, Renato + ECLINICALMEDICINE - -
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL 2023 Zambello, Renato + BLOOD ADVANCES - -
High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma 2022 Zambello, Renato + JOURNAL OF CLINICAL ONCOLOGY - -
Experts' consensus on the definition and management of high risk multiple myeloma 2022 Zambello, Renato + FRONTIERS IN ONCOLOGY - -
A bone-based 3D scaffold as an in-vitro model of microenvironment–DLBCL lymphoma cell interaction 2022 Ceccato J.Piazza M.Pizzi M.Manni S.Piazza F.Caputo I.Cinetto F.Pisoni L.Scarpa R.Zambello R.Tos A. P. D.Trentin L.Semenzato G.Vianello F. + FRONTIERS IN ONCOLOGY - -
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma 2022 Fregnani, AnnaSaggin, LaraGianesin, KettyQuotti Tubi, LauraCarraro, MarcoScapinello, GretaBonetto, GiorgiaPesavento, MariaBranca, AntonioGurrieri, CarmelaZambello, RenatoSemenzato, GianpietroTrentin, LivioManni, SabrinaPiazza, Francesco + CANCERS - -
Hypocellular myelodysplastic syndromes (h-MDS): from clinical description to immunological characterization in the Italian multi-center experience 2022 Teramo ATrimarco VVicenzetto CGasparini VRCandiotto CPizzi MBinotto GFacco MVianello FTrentin LZambello RSantini V. + LEUKEMIA - -
Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation 2022 Teramo, AntonellaBinatti, AndreaCalabretto, GiuliaVicenzetto, CristinaGasparini, Vanessa RebeccaFacco, MonicaBortoluzzi, StefaniaSemenzato, GianpietroZambello, Renato + NATURE COMMUNICATIONS - -
Mostrati risultati da 1 a 20 di 361
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile